SCHEMBL6470182

SCHEMBL6470182

NC(=O)Nc1cn(-c2ccc(-c3cccc(O)c3)c(F)c2)nc1C(N)=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 1/20 0.43
IKBKB O14920 1/20 0.42
ITK Q08881 1/20 0.41
AKR1C3 P42330 1/20 0.39
AKR1C2 P52895 1/20 0.39
MAPK10 P53779 6/20 0.38
PIK3CD O00329 1/20 0.38
PIK3CA P42336 1/20 0.38
PIK3CB P42338 1/20 0.38
PIK3CG P48736 1/20 0.38
CYP3A4 P08684 2/20 0.37
CYP2D6 P10635 2/20 0.37
FLT4 P35916 1/20 0.37
MAPK8 P45983 1/20 0.37
MAPK9 P45984 1/20 0.37
IRAK4 Q9NWZ3 1/20 0.37
PARP1 P09874 1/20 0.37
MAPKAPK2 P49137 1/20 0.36
CDK1 P06493 1/20 0.35
CCNB1 P14635 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6499580 0.89 ITK (0.39) SCN9AITKCYP3A4CYP2D6IRAK4
SCHEMBL6468674 0.88 ITK (0.43) SCN9AIKBKBITKMAPK10IRAK4
SCHEMBL6468728 0.88 IKBKB (0.42) SCN9AIKBKBITKMAPK10IRAK4
SCHEMBL6466433 0.87 SCN9A (0.45) SCN9AIKBKBITKMAPK10CYP3A4
SCHEMBL6497714 0.87 CAPN1 (0.39) SCN9AITKIRAK4PARP1KDM4E
SCHEMBL6508710 0.86 IKBKB (0.47) SCN9AIKBKBITKMAPK10IRAK4
SCHEMBL6498765 0.85 MAPT (0.46) SCN9AIKBKBITKCYP3A4IRAK4
SCHEMBL6497900 0.84 ITK (0.41) SCN9AITKIRAK4PARP1KDM4E
SCHEMBL6467585 0.84 SCN9A (0.44) SCN9AIKBKBITKMAPK10CYP3A4
SCHEMBL6505234 0.83 ITK (0.49) SCN9AIKBKBITKIRAK4PARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050197338-A1 Substituted pyrazole urea compounds for the treatment of inflammation PHARMACIA AND UPJOHN COMPANY LLC 2005-09-08 US disclosed
WO-2005037797-A1 SUBSTITUTED PYRAZOLE UREA COMPOUNDS FOR THE TREATMENT OF INFLAMMATION PHARMACIA CORPORATION (US) 2005-04-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050197338-A1 Substituted pyrazole urea compounds for the treatment of inflammation IL4, ARG2, CASP4 SCN9A 4159/4885IKBKB 664/4885ITK 4236/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.